NDC 61364-181

Rapivab

Peramivir

Rapivab is a Intravenous Solution in the Human Prescription Drug category. It is labeled and distributed by Seqirus Usa Inc.. The primary component is Peramivir.

• Product ID: 61364-181_73a559c4-e762-4227-80cf-2c8f88ea325d
• NDC: 61364-181
• Product Type: Human Prescription Drug
• Proprietary Name: Rapivab
• Generic Name: Peramivir
• Dosage Form: Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2014-12-20
• Marketing Category: NDA / NDA
• Application Number: NDA206426
• Labeler Name: Seqirus USA Inc.
• Substance Name: PERAMIVIR
• Active Ingredient Strength: 600 mg/60mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 61364-181-03

3 VIAL, GLASS in 1 CARTON (61364-181-03) > 20 mL in 1 VIAL, GLASS (61364-181-01)

• Marketing Start Date: 2014-12-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 61364-181-01 [61364018101]

Rapivab SOLUTION

• Marketing Category: NDA
• Application Number: NDA206426
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-12-20

NDC 61364-181-03 [61364018103]

Rapivab SOLUTION

• Marketing Category: NDA
• Application Number: NDA206426
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2014-12-20

Drug Details

Active Ingredients

Ingredient	Strength
PERAMIVIR	600 mg/60mL

OpenFDA Data

• SPL SET ID: 7fdedaec-9e53-4a37-a4e4-a301c8a251b8
• Manufacturer:
  • Seqirus USA Inc.
• UNII:
  • QW7Y7ZR15U
• RxNorm Concept Unique ID - RxCUI:
  • 1598082
  • 876203

NDC Crossover Matching brand name "Rapivab" or generic name "Peramivir"

NDC	Brand Name	Generic Name
61364-181	Rapivab	peramivir
72769-181	Rapivab	peramivir